In response to WFH guidelines for the management of haemophilia, 3 rd edition: Is there a difference between extended-half-life FVIII products or not?

Autor: Berntorp E; Centre for Thrombosis and Haemostasis, Lund University, Skåne University Hospital, Malmö, Sweden., Krassova S; Bayer, Basel, Switzerland., Aledort L; Division of Haematology/Oncology, Icahn School of Medicine, Mount Sinai, New York, New York, USA.
Jazyk: angličtina
Zdroj: Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2021 Nov; Vol. 27 (6), pp. e762-e764. Date of Electronic Publication: 2021 Sep 08.
DOI: 10.1111/hae.14407
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje